Key Points
- CEO Donald Young sold 56,845 shares on Nov. 13 at an average price of $3.23 for $183,609, reducing his stake by 10.32% to 494,011 shares; the sale was disclosed in an SEC filing.
- The stock is trading around $3.10 near its 52‑week low ($3.01) on above‑average volume, and the company reported an earnings miss (EPS -$0.06 vs. -$0.01 expected), revenue down 37.8% YoY, and FY2025 guidance of roughly -$4.15 to -$4.05 per share.
- Analysts have pared ratings and targets—Zacks cut to "strong sell" and Barclays lowered its price target to $4—while the consensus rating is currently "Hold" with a $12.67 average price target.
Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) CEO Donald Young sold 56,845 shares of the stock in a transaction on Thursday, November 13th. The stock was sold at an average price of $3.23, for a total transaction of $183,609.35. Following the completion of the transaction, the chief executive officer directly owned 494,011 shares in the company, valued at $1,595,655.53. The trade was a 10.32% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Aspen Aerogels Price Performance
Shares of NYSE ASPN traded down $0.13 during mid-day trading on Friday, reaching $3.10. 4,277,349 shares of the company were exchanged, compared to its average volume of 2,095,567. Aspen Aerogels, Inc. has a 52 week low of $3.01 and a 52 week high of $15.41. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. The stock has a market capitalization of $255.79 million, a PE ratio of -0.81 and a beta of 2.85. The company's 50 day moving average price is $6.97 and its 200 day moving average price is $6.69.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last released its earnings results on Thursday, November 6th. The construction company reported ($0.06) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.05). Aspen Aerogels had a negative net margin of 78.53% and a positive return on equity of 2.92%. The firm had revenue of $73.02 million during the quarter, compared to the consensus estimate of $73.42 million. During the same period in the prior year, the company earned ($0.17) EPS. The firm's revenue was down 37.8% compared to the same quarter last year. Aspen Aerogels has set its FY 2025 guidance at -4.150--4.050 EPS. Sell-side analysts forecast that Aspen Aerogels, Inc. will post 0.17 earnings per share for the current fiscal year.
Analyst Ratings Changes
Several analysts have issued reports on ASPN shares. Zacks Research lowered Aspen Aerogels from a "hold" rating to a "strong sell" rating in a research note on Monday, November 10th. Barclays lowered their price objective on shares of Aspen Aerogels from $6.00 to $4.00 and set an "underweight" rating for the company in a report on Friday, November 7th. Weiss Ratings reaffirmed a "sell (d)" rating on shares of Aspen Aerogels in a report on Wednesday, October 8th. Finally, Canaccord Genuity Group decreased their target price on shares of Aspen Aerogels from $10.00 to $5.00 and set a "buy" rating on the stock in a research report on Friday, November 7th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, two have issued a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the company presently has an average rating of "Hold" and a consensus price target of $12.67.
View Our Latest Research Report on Aspen Aerogels
Institutional Investors Weigh In On Aspen Aerogels
Institutional investors have recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC increased its position in shares of Aspen Aerogels by 1,094.8% in the second quarter. Nisa Investment Advisors LLC now owns 4,791 shares of the construction company's stock valued at $28,000 after acquiring an additional 4,390 shares during the period. SBI Securities Co. Ltd. increased its holdings in Aspen Aerogels by 67.3% during the 2nd quarter. SBI Securities Co. Ltd. now owns 6,343 shares of the construction company's stock valued at $38,000 after purchasing an additional 2,551 shares during the period. Tower Research Capital LLC TRC raised its position in Aspen Aerogels by 184.6% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,235 shares of the construction company's stock valued at $43,000 after purchasing an additional 4,693 shares during the last quarter. Acadian Asset Management LLC bought a new position in Aspen Aerogels during the 1st quarter valued at approximately $43,000. Finally, Banque Cantonale Vaudoise purchased a new stake in Aspen Aerogels in the 1st quarter worth approximately $45,000. Hedge funds and other institutional investors own 97.64% of the company's stock.
About Aspen Aerogels
(
Get Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
